Sanofi Secures FDA Nod for Sarclisa Escena
PARIS, July 10, 2026 Sanofi announced that the U.S. Food and Drug Administration (FDA) has approved Sarclisa Escena® (isatuximab-irfc)...
Advertisement
Hansoh Pharma Reports Positive Phase III Ris-Rez SCLC Results
SHANGHAI, China, July 10, 2026 Hansoh Pharmaceutical Group Co., Ltd. has announced that its Phase III ARTEMIS-008 clinical trial...
Stereotaxis Completes Robocath Acquisition to Expand Surgical Robotics Portfolio
ST. LOUIS and ROUEN, France, July 9, 2026 Stereotaxis announced the successful completion of its previously announced acquisition of...
LEO Pharma Reports Positive Phase 2 Tralokinumab Results
BALLERUP, Denmark, July 9, 2026 LEO Pharma A/S has announced positive results from the Phase 2 TRAPEDS-1 clinical trial...
Cannabix, Omega Launch DOT-Style Breath Drug Test
VANCOUVER, British Columbia, July 8, 2026 Cannabix Technologies Inc. and Omega Laboratories announced the development and validation of a...
Merck Announces Expanded FDA Approval for Keytruda in MIBC
SILVER SPRING, Maryland, July 10, 2026 Merck has received U.S. Food and Drug Administration (FDA) approval for Keytruda® (pembrolizumab)...
AstraZeneca Reports Wainua Phase III ATTR-CM Trial Results
CAMBRIDGE, United Kingdom, July 9, 2026 AstraZeneca and Ionis Pharmaceuticals have announced results from the Phase III CARDIO-TTRansform trial...
Philips Launches Alturion AI Ultrasound System for High-Volume Care
AMSTERDAM, Netherlands, July 8, 2026 Philips announced the launch of Alturion, a next-generation AI-powered ultrasound system designed to improve...
Vaccinex Showcases Pepinemab Biomarker Results
ROCHESTER, N.Y., July 8, 2026 Vaccinex announced that it will present new biomarker findings from its Phase 1b/2 SIGNAL-AD...
MAIA Biotechnology Reports Positive Phase 2 THIO-101 Data in Third-Line NSCLC
CHICAGO, July 8, 2026 MAIA Biotechnology announced encouraging interim efficacy results from Part C of its Phase 2 THIO-101...
Advertisement
